{"id":34139,"date":"2025-06-18T20:48:17","date_gmt":"2025-06-18T20:48:17","guid":{"rendered":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/"},"modified":"2025-06-18T20:48:17","modified_gmt":"2025-06-18T20:48:17","slug":"hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection","status":"publish","type":"post","link":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/","title":{"rendered":"HIV prevention drug lenacapavir approved by FDA as twice-yearly injection"},"content":{"rendered":"<p> <script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-6606220950177433\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- ItShrt World News -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-6606220950177433\"\r\n     data-ad-slot=\"1882483372\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script>\r\n<br \/>\n<\/p>\n<div id=\"\">\n<p>The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.<\/p>\n<p>The drug, called <a href=\"https:\/\/www.gilead.com\/news\/news-details\/2025\/yeztugo-lenacapavir-is-now-the-first-and-only-fda-approved-hiv-prevention-option-offering-6-months-of-protection\" target=\"_blank\" rel=\"nofollow noopener\">Yeztugo<\/a> from company Gilead Sciences, was approved Wednesday based on data from clinical trials that showed 99.9% of participants who received it remained HIV negative.<\/p>\n<p>Daniel O&#8217;Day, Gilead&#8217;s chairman and chief executive officer, called the approval a &#8220;milestone moment in the decades-long fight against HIV.&#8221;<\/p>\n<p>&#8220;Yeztugo will help us prevent HIV on a scale never seen before. We now have a way to end the HIV epidemic once and for all,&#8221; O&#8217;Day said in a news release.<\/p>\n<p>According to the Centers for Disease Control and Prevention, there were <a href=\"https:\/\/www.cdc.gov\/hiv\/data-research\/facts-stats\/index.html\" target=\"_blank\" rel=\"nofollow noopener\">31,800 estimated new HIV infections<\/a> in the United States in 2022, the most recent year with available data.<\/p>\n<p>While the drug&#8217;s approval meets an existing need, the Trump administration&#8217;s funding decisions have rolled back progress for a vaccine.<\/p>\n<p>Last month, the administration moved to end funding for a broad swath of HIV vaccine research, saying current approaches are enough to counter the virus.<\/p>\n<p>Dr. Barton Ford Haynes, the director of the Duke Human Vaccine Institute, <span class=\"link\"><a href=\"https:\/\/www.cbsnews.com\/news\/trump-administration-ending-multiple-hiv-vaccine-studies\/\" target=\"_blank\" data-invalid-url-rewritten-http=\"\">recently told CBS News<\/a><\/span> lenacapavir is a &#8220;wonderful development for the field,&#8221; but said there was still a need for a vaccine.<\/p>\n<p>&#8220;For HIV vaccine design and development, we&#8217;ve begun to see light at the end of the tunnel after many years of research,&#8221;\u00a0<a href=\"https:\/\/www.scripps.edu\/faculty\/burton\/\" target=\"_blank\" rel=\"nofollow noopener\">Dennis Burton<\/a>, an immunology professor at Scripps Research, previously told CBS News. &#8220;This is a terrible time to cut it off. We&#8217;re beginning to get close. We&#8217;re getting good results out of clinical trials.&#8221;<\/p>\n<p>Burton warned that their HIV vaccine research could not simply be turned back on, even if a future administration decided to change course on HIV funding. He said ongoing experiments would be shuttered, and researchers assembled to study the issue would be forced to refocus their careers on other topics.<\/p>\n<p>&#8220;This is a decision with consequences that will linger. This is a setback of probably a decade for HIV vaccine research,&#8221; Burton said.<\/p>\n<p class=\"content__meta--contributors\">\n<p>                                  <a href=\"https:\/\/www.cbsnews.com\/team\/dr-celine-gounder\/\" class=\"byline__author__link\" data-invalid-url-rewritten-http=\"\">Dr. C\u00e9line  Gounder<\/a> and <\/p>\n<p>                                  <a href=\"https:\/\/www.cbsnews.com\/team\/alexander-tin\/\" class=\"byline__author__link\" data-invalid-url-rewritten-http=\"\">Alexander  Tin<\/a><\/p>\n<p>        contributed to this report.\n    <\/p>\n<p>    <!-- data-recirc-source=\"queryly\" --><\/p>\n<aside class=\"component list recirculation component--type-recirculation \">\n        <\/aside>\n<p>    <!-- tags --><\/p>\n<div class=\"content-author\">\n      <a href=\"https:\/\/www.cbsnews.com\/team\/sara-moniuszko\/\" class=\"content-author__name\" data-invalid-url-rewritten-http=\"\">Sara  Moniuszko<\/a><\/p>\n<div class=\"content-author__bio\">\n<div class=\"content-author__full-information\">\n<p class=\"content-author__text\">Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper&#8217;s wellness vertical. She now covers breaking and trending news for CBS News&#8217; HealthWatch.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<p><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-6606220950177433\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- ItShrt World News -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-6606220950177433\"\r\n     data-ad-slot=\"1882483372\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script>\r\n<br \/>\n<br \/><a href=\"https:\/\/www.cbsnews.com\/news\/hiv-prevention-drug-lenacapavir-yeztugo-approved-fda\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug,<\/p>\n","protected":false},"author":1,"featured_media":34140,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[1466,232,566],"class_list":["post-34139","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-money-watch","tag-fda","tag-food-and-drug-administration","tag-hiv-aids"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>HIV prevention drug lenacapavir approved by FDA as twice-yearly injection - World News<\/title>\n<meta name=\"description\" content=\"Clinical trials showed 99.9% of participants who received the drug, called Yeztugo&#8203; from company Gilead Sciences, remained HIV negative.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HIV prevention drug lenacapavir approved by FDA as twice-yearly injection - World News\" \/>\n<meta property=\"og:description\" content=\"Clinical trials showed 99.9% of participants who received the drug, called Yeztugo&#8203; from company Gilead Sciences, remained HIV negative.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/\" \/>\n<meta property=\"og:site_name\" content=\"World News\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-18T20:48:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f\" \/><meta property=\"og:image\" content=\"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"998\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/\"},\"author\":{\"name\":\"News\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/person\/1d8ae7348e048cb7984f26b4dd818ff2\"},\"headline\":\"HIV prevention drug lenacapavir approved by FDA as twice-yearly injection\",\"datePublished\":\"2025-06-18T20:48:17+00:00\",\"dateModified\":\"2025-06-18T20:48:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/\"},\"wordCount\":399,\"publisher\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#organization\"},\"image\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1100&resize=1100,578&ssl=1\",\"keywords\":[\"FDA\",\"Food and Drug Administration\",\"HIV \/ AIDS\"],\"articleSection\":[\"Money Watch\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/\",\"url\":\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/\",\"name\":\"HIV prevention drug lenacapavir approved by FDA as twice-yearly injection - World News\",\"isPartOf\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1100&resize=1100,578&ssl=1\",\"datePublished\":\"2025-06-18T20:48:17+00:00\",\"dateModified\":\"2025-06-18T20:48:17+00:00\",\"description\":\"Clinical trials showed 99.9% of participants who received the drug, called Yeztugo&#8203; from company Gilead Sciences, remained HIV negative.\",\"breadcrumb\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#primaryimage\",\"url\":\"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1100&resize=1100,578&ssl=1\",\"contentUrl\":\"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1100&resize=1100,578&ssl=1\",\"width\":1100,\"height\":578},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/site.itshrt.com\/worldnews\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HIV prevention drug lenacapavir approved by FDA as twice-yearly injection\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#website\",\"url\":\"https:\/\/site.itshrt.com\/worldnews\/\",\"name\":\"World News\",\"description\":\"World News\",\"publisher\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/site.itshrt.com\/worldnews\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#organization\",\"name\":\"World News\",\"url\":\"https:\/\/site.itshrt.com\/worldnews\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/site.itshrt.com\/worldnews\/wp-content\/uploads\/sites\/13\/2025\/01\/cropped-download.png\",\"contentUrl\":\"https:\/\/site.itshrt.com\/worldnews\/wp-content\/uploads\/sites\/13\/2025\/01\/cropped-download.png\",\"width\":581,\"height\":581,\"caption\":\"World News\"},\"image\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/person\/1d8ae7348e048cb7984f26b4dd818ff2\",\"name\":\"News\",\"url\":\"https:\/\/site.itshrt.com\/worldnews\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HIV prevention drug lenacapavir approved by FDA as twice-yearly injection - World News","description":"Clinical trials showed 99.9% of participants who received the drug, called Yeztugo&#8203; from company Gilead Sciences, remained HIV negative.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/","og_locale":"en_US","og_type":"article","og_title":"HIV prevention drug lenacapavir approved by FDA as twice-yearly injection - World News","og_description":"Clinical trials showed 99.9% of participants who received the drug, called Yeztugo&#8203; from company Gilead Sciences, remained HIV negative.","og_url":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/","og_site_name":"World News","article_published_time":"2025-06-18T20:48:17+00:00","og_image":[{"url":"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f","type":"","width":"","height":""},{"url":"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f","width":1920,"height":998,"type":"image\/jpeg"}],"author":"News","twitter_card":"summary_large_image","twitter_image":"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f","twitter_misc":{"Written by":"News","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#article","isPartOf":{"@id":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/"},"author":{"name":"News","@id":"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/person\/1d8ae7348e048cb7984f26b4dd818ff2"},"headline":"HIV prevention drug lenacapavir approved by FDA as twice-yearly injection","datePublished":"2025-06-18T20:48:17+00:00","dateModified":"2025-06-18T20:48:17+00:00","mainEntityOfPage":{"@id":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/"},"wordCount":399,"publisher":{"@id":"https:\/\/site.itshrt.com\/worldnews\/#organization"},"image":{"@id":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#primaryimage"},"thumbnailUrl":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1100&resize=1100,578&ssl=1","keywords":["FDA","Food and Drug Administration","HIV \/ AIDS"],"articleSection":["Money Watch"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/","url":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/","name":"HIV prevention drug lenacapavir approved by FDA as twice-yearly injection - World News","isPartOf":{"@id":"https:\/\/site.itshrt.com\/worldnews\/#website"},"primaryImageOfPage":{"@id":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#primaryimage"},"image":{"@id":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#primaryimage"},"thumbnailUrl":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1100&resize=1100,578&ssl=1","datePublished":"2025-06-18T20:48:17+00:00","dateModified":"2025-06-18T20:48:17+00:00","description":"Clinical trials showed 99.9% of participants who received the drug, called Yeztugo&#8203; from company Gilead Sciences, remained HIV negative.","breadcrumb":{"@id":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#primaryimage","url":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1100&resize=1100,578&ssl=1","contentUrl":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1100&resize=1100,578&ssl=1","width":1100,"height":578},{"@type":"BreadcrumbList","@id":"https:\/\/site.itshrt.com\/worldnews\/hiv-prevention-drug-lenacapavir-approved-by-fda-as-twice-yearly-injection\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/site.itshrt.com\/worldnews\/"},{"@type":"ListItem","position":2,"name":"HIV prevention drug lenacapavir approved by FDA as twice-yearly injection"}]},{"@type":"WebSite","@id":"https:\/\/site.itshrt.com\/worldnews\/#website","url":"https:\/\/site.itshrt.com\/worldnews\/","name":"World News","description":"World News","publisher":{"@id":"https:\/\/site.itshrt.com\/worldnews\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/site.itshrt.com\/worldnews\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/site.itshrt.com\/worldnews\/#organization","name":"World News","url":"https:\/\/site.itshrt.com\/worldnews\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/logo\/image\/","url":"https:\/\/site.itshrt.com\/worldnews\/wp-content\/uploads\/sites\/13\/2025\/01\/cropped-download.png","contentUrl":"https:\/\/site.itshrt.com\/worldnews\/wp-content\/uploads\/sites\/13\/2025\/01\/cropped-download.png","width":581,"height":581,"caption":"World News"},"image":{"@id":"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/person\/1d8ae7348e048cb7984f26b4dd818ff2","name":"News","url":"https:\/\/site.itshrt.com\/worldnews\/author\/admin\/"}]}},"magazineBlocksPostFeaturedMedia":{"thumbnail":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=150&resize=150,150&ssl=1","medium":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=300&resize=300,300&ssl=1","medium_large":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=768&resize=768,0&ssl=1","large":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1024&resize=1024,1024&ssl=1","1536x1536":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1536&resize=1536,1536&ssl=1","2048x2048":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=2048&resize=2048,2048&ssl=1","colormag-highlighted-post":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=392&resize=392,272&ssl=1","colormag-featured-post-medium":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=390&resize=390,205&ssl=1","colormag-featured-post-small":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=130&resize=130,90&ssl=1","colormag-featured-image":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=800&resize=800,445&ssl=1","colormag-default-news":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=150&resize=150,150&ssl=1","colormag-featured-image-large":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1400&resize=1400,600&ssl=1","colormag-elementor-block-extra-large-thumbnail":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1155&resize=1155,480&ssl=1","colormag-elementor-grid-large-thumbnail":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=600&resize=600,417&ssl=1","colormag-elementor-grid-small-thumbnail":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=285&resize=285,450&ssl=1","colormag-elementor-grid-medium-large-thumbnail":"https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=575&resize=575,198&ssl=1"},"magazineBlocksPostAuthor":{"name":"News","avatar":"https:\/\/secure.gravatar.com\/avatar\/e85cf08852547781a5f631f3713dbb5197ed4b54e32ae19c7d5769b8c8504897?s=96&d=mm&r=g"},"magazineBlocksPostCommentsNumber":false,"magazineBlocksPostExcerpt":"The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug,","magazineBlocksPostCategories":["Money Watch"],"magazineBlocksPostViewCount":10,"magazineBlocksPostReadTime":2,"magazine_blocks_featured_image_url":{"full":["https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=1100&resize=1100,578&ssl=1",1100,578,false],"medium":["https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=300&resize=300,300&ssl=1",300,300,false],"thumbnail":["https:\/\/i2.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2025\/06\/18\/d644b4fc-dc55-4143-bc79-6a40c17bfa2f\/thumbnail\/1200x630\/eead6d960b0611875a6aec1d6b1b6258\/gilead-june-12.jpg?v=64f55bb7ef9382fe7916b907da543f1f&w=150&resize=150,150&ssl=1",150,150,false]},"magazine_blocks_author":{"display_name":"News","author_link":"https:\/\/site.itshrt.com\/worldnews\/author\/admin\/"},"magazine_blocks_comment":0,"magazine_blocks_author_image":"https:\/\/secure.gravatar.com\/avatar\/e85cf08852547781a5f631f3713dbb5197ed4b54e32ae19c7d5769b8c8504897?s=96&d=mm&r=g","magazine_blocks_category":"<a href=\"#\" class=\"category-link category-link-37\">Money Watch<\/a>","_links":{"self":[{"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/posts\/34139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/comments?post=34139"}],"version-history":[{"count":0,"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/posts\/34139\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/media\/34140"}],"wp:attachment":[{"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/media?parent=34139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/categories?post=34139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/tags?post=34139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}